Product image of Montelunio (Montelukast) supplied by GNH India

Montelunio

Active Ingredient:
Montelukast
Origin:
EU

Montelunio (Montelukast)

Montelukast, the active ingredient in Montelunio, is a leukotriene receptor antagonist presented as an oral dosage form for oral use. It is used to manage asthma, allergic rhinitis and exercise‑induced bronchoconstriction in patients who require anti‑inflammatory and bronchodilatory therapy.
GNH India supplies Montelunio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Axunio Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Montelukast acts on the leukotriene pathway to control respiratory and allergic conditions.

  • Asthma: improves control of chronic asthma and reduces the frequency of exacerbations.
  • Allergic rhinitis: relieves nasal congestion, sneezing and itching associated with seasonal allergies.
  • Exercise‑induced bronchoconstriction: prevents airway narrowing that occurs during or after physical activity.

How It Works

  • Montelukast selectively antagonizes the cysteinyl leukotriene receptor CysLT1, blocking the binding of leukotriene D4. This inhibition prevents leukotriene‑mediated bronchoconstriction, vascular permeability, and inflammatory cell recruitment in the airways, thereby reducing airway edema and hyperresponsiveness associated with asthma and allergic diseases.

Side Effects

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Upper respiratory tract infection: transient symptoms.
  • Abdominal pain: occasional discomfort.
  • Diarrhoea: mild gastrointestinal upset.
  • Cough: non‑productive.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Allergic reactions: including angioedema or anaphylaxis.
  • Neuropsychiatric events: such as agitation, depression or suicidal thoughts.
  • Hepatotoxicity: elevated liver enzymes in rare cases.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

Before initiating therapy, consider the following precautions.

  • Hypersensitivity: avoid if the patient has known allergy to montelukast or any formulation component.
  • Neuropsychiatric monitoring: observe for mood changes, depression or suicidal ideation.
  • Hepatic function: assess liver enzymes in patients with pre‑existing liver disease.
  • Pregnancy and lactation: discuss potential risks with a healthcare professional.
  • Drug interactions: review concomitant medications for possible interactions.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Avoid Interactions

Montelukast may interact with several medicines; awareness of interaction severity is essential.

Major Interactions (Avoid)

  • Phenobarbital or rifampicin: may reduce montelukast plasma concentrations.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): potential increase in exposure.

Moderate Interactions (Monitor Closely)

  • Warfarin: occasional alteration of INR; monitor coagulation parameters.
  • Beta‑agonists: additive bronchodilatory effect; assess clinical response.
  • Other leukotriene modifiers: combined use may increase risk of adverse effects.

Frequently Asked Questions

Montelunio contains montelukast, which is prescribed for the long‑term management of asthma, relief of symptoms of allergic rhinitis, and prevention of exercise‑induced bronchoconstriction. It works by reducing airway inflammation and narrowing caused by leukotrienes.

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 from binding. This action stops the cascade that leads to bronchoconstriction, mucus production, and airway swelling, thereby improving breathing and reducing allergic symptoms.

The specific dose of Montelunio is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. Dosage adjustments should follow the prescriber’s instructions and local regulatory guidelines.

Safety data for montelukast in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and discuss them with the patient before prescribing Montelunio to pregnant or nursing women.

To request Montelunio, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelunio (montelukast) belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients who prefer oral therapy or need additional control of allergic components of asthma.

Montelunio should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Montelunio is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, neuropsychiatric events like depression or suicidal thoughts, and rare liver injury. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelunio is contraindicated in individuals with known hypersensitivity to montelukast or any excipients in the formulation. Patients with a history of severe allergic reactions to leukotriene modifiers should avoid this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Montelukast

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT